Publications by authors named "Peter Fasching"

Claim this Profile
C
Clinical characterization of endometriosis phenotypes.
Louisa Hofbeck, Katharina Au, Simon Blum, Nadezda Sipulina, Laura Lotz, Peter A Fasching

Arch Gynecol Obstet· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials.
Fabio Conforti, Johannes Holtschmidt, Valentina Nekljudova, Isabella Sala, Eleonora Pagan, Peter A Fasching

Lancet Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of care before and after initial certification at a German certified hereditary breast and ovarian cancer center.
Niklas Amann, Manuel Hörner, Henrik Spannring, Lena Brückner, Julia Gocke, Peter A Fasching

J Cancer Res Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab Monotherapy Window Preceding Combined Neoadjuvant Chemotherapy and Immune Therapy in Triple-Negative Breast Cancer-The neoMono Trial.
Hans-Christian Kolberg, Johannes Schumacher, Ramona Erber, Michael Braun, Peter A Fasching

Clin Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025.
Toralf Reimer, Thorsten Kuehn, Volkmar Mueller, Nina Ditsch, Tanja Fehm, Peter A Fasching

Eur J Surg Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ribociclib Plus Endocrine Therapy in Hormone Receptor-Positive/ERBB2-Negative Early Breast Cancer: 4-Year Outcomes From the NATALEE Randomized Clinical Trial.
Peter A Fasching, Daniil Stroyakovskiy, Denise A Yardley, Chiun-Sheng Huang, John Crown

JAMA Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preventive Measures for Patients with an Elevated Genetic Risk for Gynecological Malignancies, in Particular Familial Breast and Ovarian Cancer.
Nina Ditsch, Bahriye Aktas, Maggie Banys-Paluchowski, Dorothee Speiser, Monika M Golas, Peter A Fasching

Dtsch Arztebl Int· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two Easy-to-Use Scores to Identify Acute Geriatric Patients With High Rehabilitation Success.
Julian Gutheil, Bettina Göbel, Peter Fasching, Bernhard Iglseder, Alfa Wenkstetten-Holub

J Am Med Dir Assoc· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-sectional study on user requirements for developing a digital patient navigator app.
Katharina Seitz, Manuela Langbein, Chloë Goossens, Stefanie Altmannshofer, Peter A Fasching

Digit Health· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of prenatal alcohol exposure and prenatal depressive symptoms with offspring hair cortisol in childhood and adolescence.
Anne-Christine Plank, Kerstin Panaseth-Gehle, Jennifer Gerlach, Stefan Mestermann, Peter A Fasching

BMC Psychiatry· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine Learning-Based Prediction of Distant Recurrence Risk and Ribociclib Treatment Effect in HR+/HER2- Early Breast Cancer Using Real-World and NATALEE Data.
Frederick M Howard, Peter A Fasching, Cesar A Santa-Maria, Elgene Lim, Joseph A Sparano

Clin Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating Real-World Evidence and Reported Survival Outcomes of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer.
Sarah Sammons, Denise A Yardley, Priyanka Sharma, Vijayakrishna K Gadi, Mark Pegram, Peter A Fasching

Oncol Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study Protocol of SURVIVE HERoes (NCT06643585): Trastuzumab Deruxtecan for molecular relapse in HER2+/ Low early breast cancer with ctDNA positivity after primary therapy.
Kerstin Pfister, Thomas W P Friedl, Andreas Hartkopf, Franziska Mergel, Sophia Huesmann, Peter A Fasching

PLoS One· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the potential of ChatGPT for patient identification in clinical breast cancer trials.
Annika Krückel, Peter A Fasching, Oliver Schleicher, Julia Gocke, Lena Brückner

Digit Health· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Austrian multisociety consensus on metabolic dysfunction-associated steatotic liver disease : Austrian Society of Gastroenterology and Hepatology (ÖGGH), Austrian Society of Diabetology (ÖDG), Austrian Society of Obesity (ÖAG).
Mattias Mandorfer, Georg Semmler, Elmar Aigner, Alexander Bräuer, Johanna Maria Brix, Peter Fasching

Wien Klin Wochenschr· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer.
Amandine Billaud, Gisella Figlioli, Clémence Mooser, Irene Casamassima, Violette Azzoni, Peter A Fasching

Breast· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall Survival in Metastatic Breast Cancer Patients: Real-World Data from 1,000 Patients Treated at the NCT Heidelberg between 2014 and 2022.
Laura L Michel, Manuel Feisst, Verena Thewes, Dirk Jäger, Andreas D Hartkopf, Peter A Fasching

Breast Care (Basel)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.
Dale Garsed, Tibor Zwimpfer, Sian Fereday, Ahwan Pandey, Dinuka Ariyaratne, Peter Fasching

Res Sq· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer.
Laura L Michel, Philipp Ziegler, Philipp Kreis, Andreas D Hartkopf, Markus Wallwiener, Peter A Fasching

Eur J Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: Germline and Somatic Mutations in Breast Cancer Treatment Strategies.
Eric Hahnen, Jan Hauke, Karen Gelmon, Frederik Marmé, Corinna Ernst, Peter A Fasching

JCO Precis Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The SURVIVE study (NCT05658172): Bringing breast cancer aftercare to the 21stcentury: Study protocol of a Phase III clinical trial comparing liquid biopsy guided vs. Standard of care surveillance for intermediate to high-risk breast cancer survivors.
Tatjana Braun, Sophia Huesmann, Kerstin Pfister, Thomas W P Friedl, Andreas Hartkopf, Peter A Fasching

PLoS One· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.
Kate Lawrenson, Siddhartha Kar, Karen McCue, Karoline Kuchenbaeker, Kyriaki Michailidou, Peter A Fasching

Nat Commun· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond deficiency: Clinical and molecular predictors of survival in patients with -deficient tubo-ovarian high-grade serous carcinoma.
Tibor A Zwimpfer, Sian Fereday, Ahwan Pandey, Dinuka Ariyaratne, Madawa W Jayawardana, Peter A Fasching

medRxiv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What's About Adolescent Online Gamers' Mental Health? Psychological and Cortisol-Stress-System Outcomes in Childhood and Adolescence: A Prospective Longitudinal Case-Control Study.
Stefan Mestermann, Peter A Fasching, Matthias W Beckmann, Jonas Hemetsberger, Oliver Kratz

Health Sci Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to digital pregnancy care - lessons learned from the SMART start feasibility study.
Katharina M Jaeger, Michael Nissen, Heike Leutheuser, Nina Danzberger, Adriana Titzmann, Peter A Fasching

NPJ Digit Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis